For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria—the organelles ...

In a study published in Nature on January 28, a research team led by Eric H. Xu (Xu Huaqiang) from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, along with Ma Xiong from ...

Scientists at IOCB Prague are uncovering new details of gene transcription. They have identified a previously unknown ...

In a study published in Nature on January 28, a research team led by Eric H. Xu (XU Huaqiang) from the Shanghai Institute of Materia Medica of the ...

For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria — the organelles that crank out adenosine ...

University of Toronto researchers have expanded our understanding of bacterial immunity with the discovery of a new protein ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of ...

Relay Therapeutics gets US FDA Breakthrough Therapy Designation for zovegalisib to treat advanced breast cancer: Cambridge, Massachusetts Thursday, February 5, 2026, 16:00 Hrs [IS ...

Scientists at IOCB Prague are uncovering new details of gene transcription. They have identified a previously unknown molecular mechanism by which the transcription of genetic information from ...